HALISTER1: Brazil’s Real Could Reach BRL 3.20/USD in Short Term: Quantitas

Brazil’s Real Could Reach BRL 3.20/USD in Short Term: Quantitas

(Bloomberg) -- (Machine translation provided by Google and reviewed by Bloomberg editors.)
  • The appreciation movement of emerging currencies apparently lost some strength, while external risks with Trump and the advance of plea bargains and Carwash domestically would justify that the real moved towards a slight devaluation, says João Souza Fernandes, economist at Quantitas Gestão de Recursos, in a telephone interview.
  • Stress scenario risk caused by some of Donald Trump’s attitude is still low, but higher than previously
  • Internally, “we have a framework that points to the correct direction of things, with the progress of the reforms, inflation dismantling, BC having comfortable space to lower interest rates”
  • Central Bank has left “empty space” lately, since the intervention to roll swap contracts that expire in February
    • “We would not be surprised if BC decreases swap stocks”
  • Quantitas projects the dollar rate at 3.40 reais at the end of 2017
  • NOTE: The last time BC intervened in the market with rollover swaps was on 30/1, finalizing rollover of the contracts that expired in February
Alert: HALISTER1
Source: BFW (Bloomberg First Word)

People
Donald Trump (United States of America)
Joao Souza Fernandes (Quantitas Gestao de Recursos SA)

Topics
Criminal Practice & Procedure

To de-activate this alert, click here

UUID: 7947283

HALISTER1: Plenary Health Care Partnerships Humber LP - DBRS Rating Report

Plenary Health Care Partnerships Humber LP - DBRS Rating Report

Alert: HALISTER1
Source: DBR (Dominion Bond Rating Service)

Tickers
0533793D CN (Plenary Health Care Partnerships Humber LP)

People
Suneil Ramesh (DBRS Inc)

Topics
Credit Analysis Research
Credit Research
Fixed Income Research
Investment Research
Issuer Focused Research

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

HALISTER1: Golden Credit Card Trust Series 2017-1 - Presale Report

Golden Credit Card Trust Series 2017-1 - Presale Report

Alert: HALISTER1
Source: DBR (Dominion Bond Rating Service)

People
Fanfei Gong (DBRS Ltd)
Geetika Gupta (DBRS Ltd)
Jamie Feehely (DBRS Ltd)
Paul Bretzlaff (DBRS Ltd)

Topics
Credit Analysis Research
Credit Research
Fixed Income Research
Investment Research
Reports

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

HALISTER1: U.S. Consumer ABS Issuance Overview and Outlook

U.S. Consumer ABS Issuance Overview and Outlook

Alert: HALISTER1
Source: DBR (Dominion Bond Rating Service)

People
Charles Weilamann (DBRS Inc)
Chris Donofrio (Dbrs Inc)
Chris O'Connell (DBRS Inc)
Christopher D'Onofrio (DBRS Inc)
Jayce Foxx (Dbrs Inc)

Topics
Credit Analysis Research
Credit Research
Fixed Income Research
Investment Research
Reports

To de-activate this alert, click here
To modify this alert, click here

UUID: 7947283

HALISTER: Zeltiq to Be Bought by Allergan for $2.47b, or $56.50-Share

Zeltiq to Be Bought by Allergan for $2.47b, or $56.50-Share

(Bloomberg) -- Zeltiq to be bought by Allergan for $56.50-share cash, or 14% premium to Feb. 10 close.
  • Allergan sees deal immediately accretive, will host call 9am
  • ZLTQ halted
To contact the reporter on this story: Arie Shapira in New York at ashapira3@bloomberg.net
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
AGN US (Allergan PLC)
ZLTQ US (Zeltiq Aesthetics Inc)

To de-activate this alert, click here

UUID: 7947283